The regulators have not revoked approval of Pfizer's vaccine, which was approved by the FDA in late 2020, even after Brook Jackson disclosed problems at sites managed by Ventavia Research Group. Now, Pfizer is asking to dismiss the lawsuit revealing problems at COVID-19 vaccine trial sites entirely.
Pfizer has requested a US court to dismiss a case filed by a whistleblower who exposed flaws at Pfizer's COVID-19 vaccine testing facility.
In a lawsuit disclosed in February, whistleblowe...
